Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
31.09
+1.43 (4.82%)
Aug 7, 2026, 11:05 AM EDT - Market open

Hims & Hers Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Net Income
-92.1220.615.7742.5149.4926.0375.5913.311.131.25-7.57-7.16-10.07-10.91-18.84-19.68-16.25-31.16-15.94-9.15
Depreciation & Amortization
21.9518.0917.6710.478.286.064.383.6432.662.362.382.122.011.91.821.741.631.550.51
Stock-Based Compensation
36.8634.4940.1735.7324.8624.3524.924.0419.0317.7917.2816.8514.1712.3510.9810.638.8611.9511.879.16
Other Adjustments
55.214.617.36-6.282.18-7.63-54.82-0.63-0.02-0.570.8-0.410.821.370.820.160.710.08-9.49-7.08
Change in Receivables
-116.25----0.86---------------
Changes in Inventories
-20.326.3837.27-65.7-11.67-15.32-8.17-10.76-7.36-0.47-0.58-0.720.870.79-2.67-7.531.42-2.7-3.88-2.07
Changes in Accounts Payable
167.64-45.870.95-9.3314.478.6618.912.553.62.92-1.041.483.96-0.615.883.194.273.55-1.052.24
Changes in Accrued Expenses
10.02-1.91-52.887.394.359.7914.032.23-2.261.617.755.491.67-4.615.373.3-3.150.99-6.384.47
Changes in Unearned Revenue
37.988.5319.95-12.3535.4843.111.197.2663.342.33-0.811.39-0.65-0.211.19-2.041.20.470.4
Changes in Other Operating Activities
-11.640.76-15.16-22.41-17.48-8.65-0.734.67-7.29-6.543.87-0.27-5.44-6.462.760.53-14.940.186.892.13
Operating Cash Flow
89.3661.31148.72-19.12109.0986.3985.2753.5925.8421.9825.1916.839.48-6.725.99-6.39-19.4-3.11-15.960.6
Operating Cash Flow Growth (YoY)
-18.09%-29.03%74.42%-322.21%292.96%238.48%218.52%172.47%-320.90%---------88.14%
Capital Expenditures
-29.84-59.39-65.27-46.07-55.33-24.52-3.34-3.21-10.58-8.63-3.28-4.68-0.64-1.4-1.04-0.18-0.1-0.55-0.16-0.06
Purchases of Intangible Assets
-6.48-4.49-4.09-4.25-3.71-2.37-2.54-2.81-3.38-2.57-2.64-2.19-1.88-1.21-0.92-1.2-1.2-0.93-1.41-1.09
Purchases of Investments
-11.22-12.28-713.56---9.97-53.06-26.84-70.7-20.82-71.04-24.69-40.69-50.88-47.67-4.27-84.88-47.27-31.84-15.5
Proceeds from Sale of Investments
169.9635.9412.1929.2331.3419.6563.228.497.752.7245.933.2539.0859.547.0618.92104.635953.240.14
Cash Acquisitions
-137.87-23.45-116.670-5.10-15.4------00--0-45.72-
Investing Cash Flow
-15.45-83.68-887.4-21.09-32.8-17.21-10.41-4.4713.0420.7-31.062.37-4.116-2.5812.8218.4510.24-25.9222.74
Issuance of Common Stock
5.014.713.32.573.9310.432.0311.45.072.031.130.320.250.710.690.580.890.690.290.18
Repurchase of Common Stock
--80.48-9.48---5.01-30.04-19.93-28.06-20------000
Net Common Stock Issued (Repurchased)
5.01-75.77-6.182.573.935.42-28.01-8.53-22.990.031.130.320.250.710.690.580.890.690.290.18
Other Financing Activities
-82.89-21.75-32.83-38.57-26.95-19.41-10.82-14.97-7.31-4-2.69-3.75-3.66-11.17-1.18-0.78-23.42-0.76-0.78-4.52
Financing Cash Flow
-77.88-97.52-39.01-36-23.02-13.65-38.82-25.07-30.31-3.96-1.56-2.54-3.41-10.46-0.490.35-22.53-0.08-0.48-4.34
Foreign Exchange Rate Adjustments
-2.38---0.24---------------
Net Cash Flow
-6.35-119.89-777.69-76.2153.5255.5336.0324.068.5738.72-7.4316.661.96-11.182.926.78-23.487.06-42.3719
Free Cash Flow
59.511.9283.46-65.1853.7661.8781.9350.3815.2613.3521.9112.158.85-8.124.95-6.57-19.5-3.66-16.120.54
Free Cash Flow Growth (YoY)
10.69%-96.89%1.87%-252.38%363.34%273.85%314.70%72.43%-342.98%---------88.06%
FCF Margin
9.79%0.31%13.93%-11.96%9.17%12.86%20.40%15.96%5.48%5.41%9.67%5.84%4.64%-4.86%3.42%-5.79%-19.25%-4.32%-21.73%0.89%
Free Cash Flow Per Share
0.260.010.34-0.250.220.260.350.210.070.060.100.060.04-0.040.02-0.03-0.10-0.02-0.080.00
Levered Free Cash Flow
83.69-32.7328.3-95.4927.5945.15111.8529.68-3.76-3.873.87-4.29-6.14-21.84-6.86-17.36-29.06-26.87-18.5-1.54
Unlevered Free Cash Flow
104.76-43.0227.77-103.4225.4640.83107.9427.31-6-5.342.08-6.35-7.79-22.41-7.98-17.88-29.83-17.21-25.63-9.86
SEC Filings: 10-K · 10-Q